Research on HLA-G: an update.
Human leukocyte antigen (HLA)-G is a nonclassical HLA class I molecule from the major histocompatibility complex, which was initially shown to confer protection to the fetus from her mother's immune system. The Third International Conference on HLA-G, held in 2003, showed that beyond its role in fetal-maternal tolerance, HLA-G exerts tolerogenic functions involved in transplant acceptance as well as in tumoral and viral immune escape. The Fourth International Conference, which took place in Paris on July 2006, counted 72 oral presentations and about 200 attendees from 25 countries. The reports presented brought new insight into HLA-G research, and we summarize here the major advances on the HLA-G biology that were reported. Abstracts for all presentations can be found in volume 68 issue number 4 of Tissue Antigens.
Favier
B
B
Service de Recherches en Hemato-Immunologie, Commissariat a l'Energie Atomique DSV-DRM, Hopital Saint-Louis, IUH, 1, Avenue Claude Vellefaux, 75475 Paris Cedex 10, France.
LeMaoult
J
J
Rouas-Freiss
N
N
Moreau
P
P
Menier
C
C
Carosella
E D
ED
D035843:Biomedical Research / Q000639:trends; D005260:Female; D006680:HLA Antigens / Q000276:immunology*; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance / Q000502:physiology*; D008297:Male; D011247:Pregnancy / Q000276:immunology*; D019139:Tumor Escape / Q000276:immunology*
D006680:HLA Antigens; D059951:HLA-G Antigens; D015395:Histocompatibility Antigens Class I